FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Aug 6, 2014
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on August 6, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- August 6, 2014
- Product Type
- Biologics
View Company Profile
ID · fcb1ba80-72fd-4a84-9cc0-ce573bfc97e7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 890539
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 11, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1331976 - 2026-08-11
- FDA Inspection 1170457 - 2022-05-12
- FDA Inspection 1114211 - 2019-10-24
- FDA Inspection 1041438 - 2018-01-11
- FDA Inspection 761649 - 2011-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.